Erratum: Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage after Percutaneous Coronary Intervention for Non-ST-Segment Elevation Myocardial Infarction: Results of the SELECT-ACS Trial (Journal of the American College of Cardiology (2013) 61 (2048-2055))

J. C. Tardif, J. F. Tanguay, S. S. Wright, V. Duchatelle, T. Petroni, J. C. Grégoire, R. Ibrahim, T. M. Heinonen, S. Robb, O. F. Bertrand, D. Cournoyer, D. Johnson, J. Mann, M. C. Guertin, P. L. L'Allier

Research output: Contribution to journalComment/debatepeer-review

Fingerprint Dive into the research topics of 'Erratum: Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage after Percutaneous Coronary Intervention for Non-ST-Segment Elevation Myocardial Infarction: Results of the SELECT-ACS Trial (Journal of the American College of Cardiology (2013) 61 (2048-2055))'. Together they form a unique fingerprint.